![Pharmacokinetics, Pharmacodynamics, and Dose Optimization of Cefiderocol during Continuous Renal Replacement Therapy | SpringerLink Pharmacokinetics, Pharmacodynamics, and Dose Optimization of Cefiderocol during Continuous Renal Replacement Therapy | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs40262-021-01086-y/MediaObjects/40262_2021_1086_Fig2_HTML.png)
Pharmacokinetics, Pharmacodynamics, and Dose Optimization of Cefiderocol during Continuous Renal Replacement Therapy | SpringerLink
![PDF] Pharmacokinetic and Pharmacodynamic Profiles of Cefiderocol, a Novel Siderophore Cephalosporin | Semantic Scholar PDF] Pharmacokinetic and Pharmacodynamic Profiles of Cefiderocol, a Novel Siderophore Cephalosporin | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/b0d09a3defaaad638f31906e277fb961bed2164b/2-Table1-1.png)
PDF] Pharmacokinetic and Pharmacodynamic Profiles of Cefiderocol, a Novel Siderophore Cephalosporin | Semantic Scholar
![Cefiderocol: A Novel Siderophore Cephalosporin against Multidrug‐Resistant Gram‐Negative Pathogens - Abdul‐Mutakabbir - 2020 - Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy - Wiley Online Library Cefiderocol: A Novel Siderophore Cephalosporin against Multidrug‐Resistant Gram‐Negative Pathogens - Abdul‐Mutakabbir - 2020 - Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy - Wiley Online Library](https://accpjournals.onlinelibrary.wiley.com/cms/asset/1e5d546a-cbee-4b93-b02a-24de569fa657/phar2476-fig-0002-m.jpg)
Cefiderocol: A Novel Siderophore Cephalosporin against Multidrug‐Resistant Gram‐Negative Pathogens - Abdul‐Mutakabbir - 2020 - Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy - Wiley Online Library
![Antibiotics | Free Full-Text | Cefiderocol in Critically Ill Patients with Multi-Drug Resistant Pathogens: Real-Life Data on Pharmacokinetics and Microbiological Surveillance Antibiotics | Free Full-Text | Cefiderocol in Critically Ill Patients with Multi-Drug Resistant Pathogens: Real-Life Data on Pharmacokinetics and Microbiological Surveillance](https://www.mdpi.com/antibiotics/antibiotics-10-00649/article_deploy/html/images/antibiotics-10-00649-g001-550.jpg)
Antibiotics | Free Full-Text | Cefiderocol in Critically Ill Patients with Multi-Drug Resistant Pathogens: Real-Life Data on Pharmacokinetics and Microbiological Surveillance
![Antibiotics | Free Full-Text | Cefiderocol in Critically Ill Patients with Multi-Drug Resistant Pathogens: Real-Life Data on Pharmacokinetics and Microbiological Surveillance Antibiotics | Free Full-Text | Cefiderocol in Critically Ill Patients with Multi-Drug Resistant Pathogens: Real-Life Data on Pharmacokinetics and Microbiological Surveillance](https://www.mdpi.com/antibiotics/antibiotics-10-00649/article_deploy/html/images/antibiotics-10-00649-g001.png)
Antibiotics | Free Full-Text | Cefiderocol in Critically Ill Patients with Multi-Drug Resistant Pathogens: Real-Life Data on Pharmacokinetics and Microbiological Surveillance
![Empiric treatment of patients with sepsis and septic shock and place in therapy of cefiderocol: a systematic review and expert opinion statement | Journal of Anesthesia, Analgesia and Critical Care | Full Text Empiric treatment of patients with sepsis and septic shock and place in therapy of cefiderocol: a systematic review and expert opinion statement | Journal of Anesthesia, Analgesia and Critical Care | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs44158-022-00062-7/MediaObjects/44158_2022_62_Fig3_HTML.png)
Empiric treatment of patients with sepsis and septic shock and place in therapy of cefiderocol: a systematic review and expert opinion statement | Journal of Anesthesia, Analgesia and Critical Care | Full Text
![Cefiderocol versus imipenem-cilastatin for the treatment of complicated urinary tract infections caused by Gram-negative uropathogens: a phase 2, randomised, double-blind, non-inferiority trial - The Lancet Infectious Diseases Cefiderocol versus imipenem-cilastatin for the treatment of complicated urinary tract infections caused by Gram-negative uropathogens: a phase 2, randomised, double-blind, non-inferiority trial - The Lancet Infectious Diseases](https://www.thelancet.com/cms/attachment/550f2e4e-05ac-4b4b-b898-ad5e2e9d6e09/gr1.gif)
Cefiderocol versus imipenem-cilastatin for the treatment of complicated urinary tract infections caused by Gram-negative uropathogens: a phase 2, randomised, double-blind, non-inferiority trial - The Lancet Infectious Diseases
![Antibiotics | Free Full-Text | Validation and Application of an HPLC-UV Method for Routine Therapeutic Drug Monitoring of Cefiderocol Antibiotics | Free Full-Text | Validation and Application of an HPLC-UV Method for Routine Therapeutic Drug Monitoring of Cefiderocol](https://www.mdpi.com/antibiotics/antibiotics-10-00242/article_deploy/html/images/antibiotics-10-00242-g001.png)
Antibiotics | Free Full-Text | Validation and Application of an HPLC-UV Method for Routine Therapeutic Drug Monitoring of Cefiderocol
![Cefiderocol, a Siderophore Cephalosporin for Gram‐Negative Bacterial Infections: Pharmacokinetics and Safety in Subjects With Renal Impairment - Katsube - 2017 - The Journal of Clinical Pharmacology - Wiley Online Library Cefiderocol, a Siderophore Cephalosporin for Gram‐Negative Bacterial Infections: Pharmacokinetics and Safety in Subjects With Renal Impairment - Katsube - 2017 - The Journal of Clinical Pharmacology - Wiley Online Library](https://accp1.onlinelibrary.wiley.com/cms/asset/3f9562bb-0c90-43a4-bcef-22858332274d/jcph841-fig-0002-m.jpg)
Cefiderocol, a Siderophore Cephalosporin for Gram‐Negative Bacterial Infections: Pharmacokinetics and Safety in Subjects With Renal Impairment - Katsube - 2017 - The Journal of Clinical Pharmacology - Wiley Online Library
![PDF] Pharmacokinetic and Pharmacodynamic Profiles of Cefiderocol, a Novel Siderophore Cephalosporin | Semantic Scholar PDF] Pharmacokinetic and Pharmacodynamic Profiles of Cefiderocol, a Novel Siderophore Cephalosporin | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/b0d09a3defaaad638f31906e277fb961bed2164b/4-Table2-1.png)
PDF] Pharmacokinetic and Pharmacodynamic Profiles of Cefiderocol, a Novel Siderophore Cephalosporin | Semantic Scholar
![Cefiderocol dose-response curves. This figure appears in colour in the... | Download Scientific Diagram Cefiderocol dose-response curves. This figure appears in colour in the... | Download Scientific Diagram](https://www.researchgate.net/publication/361939449/figure/fig1/AS:1177272463699975@1657695036637/Cefiderocol-dose-response-curves-This-figure-appears-in-colour-in-the-online-version-of.jpg)
Cefiderocol dose-response curves. This figure appears in colour in the... | Download Scientific Diagram
![Cefiderocol, a New Siderophore Cephalosporin for the Treatment of Complicated Urinary Tract Infections Caused by Multidrug-Resistant Pathogens: Preclinical and Clinical Pharmacokinetics, Pharmacodynamics, Efficacy and Safety | springermedizin.de Cefiderocol, a New Siderophore Cephalosporin for the Treatment of Complicated Urinary Tract Infections Caused by Multidrug-Resistant Pathogens: Preclinical and Clinical Pharmacokinetics, Pharmacodynamics, Efficacy and Safety | springermedizin.de](https://media.springernature.com/lw150/springer-static/cover/journal/40261/40/10.jpg?as=jpg)
Cefiderocol, a New Siderophore Cephalosporin for the Treatment of Complicated Urinary Tract Infections Caused by Multidrug-Resistant Pathogens: Preclinical and Clinical Pharmacokinetics, Pharmacodynamics, Efficacy and Safety | springermedizin.de
![Mean (SD) plasma concentrations of cefiderocol following multiple-dose... | Download Scientific Diagram Mean (SD) plasma concentrations of cefiderocol following multiple-dose... | Download Scientific Diagram](https://www.researchgate.net/publication/322316200/figure/fig1/AS:662954269741056@1535072023526/Mean-SD-plasma-concentrations-of-cefiderocol-following-multiple-dose-administration-at.png)
Mean (SD) plasma concentrations of cefiderocol following multiple-dose... | Download Scientific Diagram
![Pharmacokinetics, Safety, and Tolerability of Cefiderocol, a Novel Siderophore Cephalosporin for Gram-Negative Bacteria, in Healthy Subjects | Antimicrobial Agents and Chemotherapy Pharmacokinetics, Safety, and Tolerability of Cefiderocol, a Novel Siderophore Cephalosporin for Gram-Negative Bacteria, in Healthy Subjects | Antimicrobial Agents and Chemotherapy](https://journals.asm.org/cms/10.1128/AAC.02163-17/asset/28d6dda1-bd54-4fee-8941-49872c44b0a5/assets/graphic/zac0031869590001.jpeg)
Pharmacokinetics, Safety, and Tolerability of Cefiderocol, a Novel Siderophore Cephalosporin for Gram-Negative Bacteria, in Healthy Subjects | Antimicrobial Agents and Chemotherapy
![Cefiderocol dose-response curves. This figure appears in colour in the... | Download Scientific Diagram Cefiderocol dose-response curves. This figure appears in colour in the... | Download Scientific Diagram](https://www.researchgate.net/profile/Christopher-Frohlich/publication/361939449/figure/fig1/AS:1177272463699975@1657695036637/Cefiderocol-dose-response-curves-This-figure-appears-in-colour-in-the-online-version-of_Q640.jpg)
Cefiderocol dose-response curves. This figure appears in colour in the... | Download Scientific Diagram
![Pharmacokinetics, Safety, and Tolerability of Cefiderocol, a Novel Siderophore Cephalosporin for Gram-Negative Bacteria, in Healthy Subjects | Antimicrobial Agents and Chemotherapy Pharmacokinetics, Safety, and Tolerability of Cefiderocol, a Novel Siderophore Cephalosporin for Gram-Negative Bacteria, in Healthy Subjects | Antimicrobial Agents and Chemotherapy](https://journals.asm.org/cms/10.1128/AAC.02163-17/asset/56383d0a-9d8b-4b32-bce1-f5c189aecd63/assets/graphic/zac0031869590004.jpeg)
Pharmacokinetics, Safety, and Tolerability of Cefiderocol, a Novel Siderophore Cephalosporin for Gram-Negative Bacteria, in Healthy Subjects | Antimicrobial Agents and Chemotherapy
![Frontiers | Cefiderocol for the Treatment of Multidrug-Resistant Gram-Negative Bacteria: A Systematic Review of Currently Available Evidence Frontiers | Cefiderocol for the Treatment of Multidrug-Resistant Gram-Negative Bacteria: A Systematic Review of Currently Available Evidence](https://www.frontiersin.org/files/Articles/896971/fphar-13-896971-HTML-r1/image_m/fphar-13-896971-g002.jpg)